These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Protection against chromosome degradation at the telomeres. Grandin N; Charbonneau M Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802 [TBL] [Abstract][Full Text] [Related]
5. The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Verdun RE; Karlseder J Cell; 2006 Nov; 127(4):709-20. PubMed ID: 17110331 [TBL] [Abstract][Full Text] [Related]
6. Functional links between telomeres and proteins of the DNA-damage response. d'Adda di Fagagna F; Teo SH; Jackson SP Genes Dev; 2004 Aug; 18(15):1781-99. PubMed ID: 15289453 [TBL] [Abstract][Full Text] [Related]
7. Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Verdun RE; Crabbe L; Haggblom C; Karlseder J Mol Cell; 2005 Nov; 20(4):551-61. PubMed ID: 16307919 [TBL] [Abstract][Full Text] [Related]
8. The role of telomeres and telomerase in the pathology of human cancer and aging. Shin JS; Hong A; Solomon MJ; Lee CS Pathology; 2006 Apr; 38(2):103-13. PubMed ID: 16581649 [TBL] [Abstract][Full Text] [Related]
9. The role of the DNA damage checkpoint in regulation of translesion DNA synthesis. Koren A Mutagenesis; 2007 May; 22(3):155-60. PubMed ID: 17290049 [TBL] [Abstract][Full Text] [Related]
10. DNA damage checkpoints in mammals. Niida H; Nakanishi M Mutagenesis; 2006 Jan; 21(1):3-9. PubMed ID: 16314342 [TBL] [Abstract][Full Text] [Related]
11. Those dam-aged telomeres! Harrington L Curr Opin Genet Dev; 2004 Feb; 14(1):22-8. PubMed ID: 15108801 [TBL] [Abstract][Full Text] [Related]
12. Telomere and telomerase modulation by the mammalian Rad9/Rad1/Hus1 DNA-damage-checkpoint complex. Francia S; Weiss RS; Hande MP; Freire R; d'Adda di Fagagna F Curr Biol; 2006 Aug; 16(15):1551-8. PubMed ID: 16890531 [TBL] [Abstract][Full Text] [Related]
13. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process. Raynaud CM; Sabatier L; Philipot O; Olaussen KA; Soria JC Crit Rev Oncol Hematol; 2008 May; 66(2):99-117. PubMed ID: 18243729 [TBL] [Abstract][Full Text] [Related]
14. Telomeres rather than telomerase a key target for anti-cancer therapy? Boukamp P; Mirancea N Exp Dermatol; 2007 Jan; 16(1):71-9. PubMed ID: 17181645 [TBL] [Abstract][Full Text] [Related]
15. Early replication of short telomeres in budding yeast. Bianchi A; Shore D Cell; 2007 Mar; 128(6):1051-62. PubMed ID: 17382879 [TBL] [Abstract][Full Text] [Related]
16. Cytogenetics for the study of telomere function in plants. Siroky J Cytogenet Genome Res; 2008; 122(3-4):374-9. PubMed ID: 19188708 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
19. Telomerase as a clinical target: current strategies and potential applications. Fleisig HB; Wong JM Exp Gerontol; 2007; 42(1-2):102-12. PubMed ID: 16814507 [TBL] [Abstract][Full Text] [Related]